ALTO-100 for bipolar depression
Part of Mental health clinical trials.
This trial tests an investigational drug called ALTO-100 in people with bipolar I or II who are currently experiencing depression. It looks at whether this new medicine can help improve depression symptoms when taken alongside your usual mood stabilizer or antipsychotic medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with bipolar I or II and are currently in a depressive episode.
- You are taking a mood stabilizer (like lithium, lamotrigine, or valproic acid) or an approved atypical antipsychotic for at least 6 weeks, with no dose changes in the last 2 weeks.
- You are willing to follow the study schedule and all procedures.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have any unstable medical conditions, substance use disorder, or a history of allergy to ALTO-100.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ALTO-300 as an add-on treatment for people with moderate to severe major depressive disorder (MDD). It aims to see whether ALTO-300 helps improve depression symptoms when you’re already on a stable antidepressant.
This trial tests an experimental pill (ABB-932) for people with bipolar I or II disorder who are currently in a depressive episode. The goal is to see if the drug is safe and helps improve mood.
This trial tests whether the study drug azetukalner can help reduce depression symptoms in people with bipolar I or II disorder who are currently having a depressive episode. You would be randomly assigned to receive either the drug or a placebo (inactive pill) to see which works better.
This study tests an investigational drug called BMS-986511 in adults with moderate to severe depression. The goal is to see if it can improve symptoms.
This study tests whether a new medication called ALTO-207 can help people with depression that hasn't improved with standard antidepressants. You may qualify if you've tried multiple antidepressants without enough relief and are willing to add this experimental treatment to your current medication.
This study tests an experimental medication called ALTO-101 for people with schizophrenia who also have cognitive impairment (memory or thinking problems). It aims to see if the drug can improve these symptoms while you continue your current antipsychotic treatment.
Hear when a new Bipolar Disorder I or II With a Major Depressive Episode trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.